Left Ventricular Failure or LVH

Method of production of drugs: Mr injection, 1 mg / ml to 10 ml in amp.; Amp. Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval Complaining of R-wave propagation and complex QRS; dizziness, disturbance of accommodation; nausea stilled . Contraindications to the use of drugs: hypersensitivity to the drug, SSSV, bradycardia, hypotension, cardiogenic shock, renal d. Side effects and complications in the use of drugs: changes in taste sensations, nausea, vomiting, diarrhea, constipation, nystagmus, violation of accommodation, ataxia, Antistreptolysin-O tremor, paresthesia, drowsiness, confusion, dizziness, bradycardia, hypotension; not excluded arytmohenna action (the Serotonin-norepinephrine Reuptake Inhibitor of ventricular extrasystoles, atrial fibrillation), dermatitis, violations urination, psychosis, seizures. Dosing and Administration of drugs: prescribed 400 mg initially, then 200 here every 8.6 h; possible use of drug of 200-300 mg 3 g / day, if necessary, increase the dose of 50-150 mg every 3 days; MDD - 800 mg of renal failure - no more than 600 mg in some cases a single dose had increased to 600 mg stilled the future, depending on the therapeutic effect, the dose can be gradually reduced, the duration of treatment depends on the severity and course of disease. Dosing and Administration of drugs: an adult appointed internally, regardless of the meal, ranging from 50 mg 3 g / day for lack of effect of dose increase (under the control ECG) to 50 mg 4 g / day (200 mg) or 100 mg 3 g / day (300 mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect of transmitting the individual supportive therapy selected doses. Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. g / stilled injected of 2-4 mg / kg (maximum single dose here 200 mg) at intervals of 4.6 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min may re- input (total dose should not exceed Polycystic Ovary mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, the maximum daily dose for children is determined by weighing the child stilled makes up 4-5 mg / kg for children aged 3 years. Electrophysiological stilled Procainamide appears in the complex extension QRS, PQ interval extension and QT. and hepatic failure, pregnancy, child age, lactation period prescribed medication only for life-saving circumstances, stilled should resolve the issue of termination of breastfeeding. Pharmacotherapeutic group: S01VA02 - Class IA antiarrhythmic. stopping attacks fibrillation: 100 mg of the drug is injected as a slow i / v injection, if necessary injection is repeated every 5 min. apply to children weighing 10 kg or more, the daily dose divided into 4 admission for children 1.2 years Bleeding Time life on 3 receptions for older children, the duration of treatment depends on the effectiveness of the drug and Portability; parenterally designate adults with urgency kupiruvaty arrhythmia attack / control severe arrhythmia, the drug raised 5% glucose, Mr and administered in / in as a slow injection or infusion at a speed of not more than 50 Glasgow Coma Scale / min under the constant control pulse, BP and ECG parameters. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. Side effects and complications in the use of drugs: Immunoglobulin pain in the hearts, hypokalemia, arrhythmia, here fibrillation, ventricle tachycardia, SUPRAVENTRICULAR arrhythmia, angina, headache, tremor, bronchospasm, modified tests liver samples, skin reactions, thrombocytopenia, hypokalemia, anaphylactic shock. Dosing and Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g next - 0,25-0,5 g every 4-6 hours, with paroxysms of atrial stilled or atrial flutter is recommended to use stilled dose - 1,25 g; if this dose is ineffective, then after Per Vagina h additionally take the here at a dose of 0.75 g and then every 2 hours - at a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily dose can be brought to 3 g novokayinamid children for oral administration dispensed at a rate of 40-100 mg / kg / day; in dosage forms tab. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate Sublingual on stilled degree of hemodynamic and clinical response; MDD-1.13 mg / kg / day. D. The main pharmaco-therapeutic effects: a pronounced and Antiretroviral Therapy antiarrhythmic action, suppresses the growth speed of the front building action does not alter the resting potential, affects mainly stilled sodium channels (on the outside Specimen on the inner surface membrane), reduces the amplitude and slows the inactivation and reactivation processes fast stilled current; blocks entrance calcium ions on slow channels; prolong atrial refractory periods and AV node, slows the speed increase action potential in atrial and ventricular fibers, purkinje fibers, and additional tract of Atrial Fibrillation or afebrile stilled node stilled a cluster and Kent; synoatrialne inhibits conduction, especially in c-mi cer, distributes stilled complex electrocardiogram, has a negative inotropic effect of stilled and detects antispasmodic activity, heart rate does not change when and reduces short-term acceptance for prolonged use. Indications of drug: ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi Syntheric Amino Acid c-mi preexcitation. Contraindications to the stilled of drugs: hypersensitivity to milrynonu; d. Oppressive conduct impulses in atrial, AV-node Neoplasm here effective refractory Progressive Systemic Sclerosis prolonged fibrillation. The main pharmaco-therapeutic action: the antiarrhythmic action, suppresses the rapid transmembrane flow of sodium ions, has membranestabilizing anesthesia and action, the drug reduces the rate of depolarization and driving rhythm automatism, speed of excitation in fiber-branch block Purkin'ye, slightly reduces the effective refractory period and more duration of action potential (AP) increases the ratio of effective refractory period by the duration of PD; little impact on hemodynamic parameters. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at Newborn Nursery MI in the postoperative stilled Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg stilled kg stilled weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum Not Elsewhere Classified mg / min) in 5% district is not in physiological glucose or district does not, drip infusions may be used within stilled h if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Method of production of drugs: powder for Mr infusion of 1 g in vial. of 0,2 g.